Fludeoxyglucose F-18 Injection
Product Images NDC 24450-647

2 FDA label images from Brigham And Women`s Hospital, Inc., The · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fludeoxyglucose F-18 (NDC 24450-647). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Brigham And Women`s Hospital, Inc., The, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image Of Chemical Structure (Chemical Structure)

Image Of Chemical Structure (Chemical Structure)
Chemical structure of Fludeoxyglucose F-18, showing its molecular arrangement with fluorine-18 isotope labeled.*
FDA Label Image

Drug Product Label (Fdglabel)

Drug Product Label (Fdglabel)
Label for Fludeoxyglucose F-18 Injection, 300 mCi/mL, an intravenous diagnostic agent supplied as a multiple dose vial. The label includes calibration, volume, expiration details, and handling instructions. The product is manufactured by Brigham and Women's Hospital, Inc., located in Boston, MA, and includes the NDC number 24450-647-30.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.